Please contact our sales representative to learn more information about this reagents.
Background
Abrilumab (INN, development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease. This drug was developed by MedImmune.